Three Circulating miRNAs Related to Non-Small-Cell Lung Cancer Progression: An Integrative Analysis of Their...

Area of Science:

• Molecular Biology
• Oncology
• Biomarker Discovery

Background:

• MicroRNAs (miRNAs) play vital roles in cellular processes and disease, serving as potential biomarkers.
• Distinct miRNA expression patterns differentiate lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) from normal tissues.
• Circulating miRNAs are implicated in the progression of non-small-cell lung cancer (NSCLC).

Purpose of the Study:

• To identify and elucidate the biological functions of key differentially expressed miRNAs (DE-miRNAs) in NSCLC.
• To construct a regulatory network involving significant DE-miRNAs and their target genes.
• To evaluate the potential of specific miRNAs as diagnostic and prognostic biomarkers for NSCLC.

Main Methods:

• Analysis of The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets to identify DE-miRNAs.
• Protein-protein interaction (PPI) analysis and construction of a miRNA-hub gene regulatory network.
• Functional assays (EdU and wound healing) in A549 lung cancer cells to assess miRNA biological functions.

Main Results:

• Identified hsa-miR-451a, hsa-miR-139-5p, and hsa-miR-126-5p as the most significant DE-miRNAs in NSCLC.
• Established a regulatory network demonstrating interactions between these miRNAs and cancer-related target genes.
• Functional assays indicated the involvement of these miRNAs in cell proliferation and migration.

Conclusions:

• The identified miRNAs (hsa-miR-451a, hsa-miR-139-5p, hsa-miR-126-5p) show potential as biomarkers for NSCLC.
• These miRNAs may contribute to lung cancer progression through the modulation of cancer-related targets.
• Further research into the mechanistic roles of these miRNAs could reveal novel therapeutic strategies for NSCLC.